ST Renfu (600079)
SSE · 600079
Market Cap$28.3B
Revenue$23.9B
Employees17153
Listed OnSSE
Ticker600079
CEO / ExecMr. Wentao Du
HeadquartersWuhan
MarketMainland China
Websitewww.humanwell.com.cn
Overview
Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for patients who require opioid analgesia; nabuphine hydrochloride injection for use as an analgesic for an
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.